In a major policy shift, the Trump administration's marijuana reclassification order eased restrictions while creating new questions for HR.

The federal government is reclassifying medical marijuana, categorizing it as a drug with potential medical benefits and less potential for harm. While this doesn’t legalize marijuana nationally, it does open the door for further research into its effects.

By Puyaan Singh and Christy Santhosh April 30 (Reuters) - Companies developing cannabis-based medicines say U.S. moves to loosen restrictions on the drug could unlock private funding and the public markets,

The federal government reclassified marijuana from Schedule I to Schedule III, impacting Oklahoma's medical marijuana businesses.

On April 22, Bloomberg reported, citing an on-air discussion with CEO Irwin Simon, that Tilray Brands, Inc. (NASDAQ:TLRY) shares rose by around 10% after surging as much as 18% ea

The DEA announced the new requirements for medical marijuana dispensaries seeking federal compliance, including application details and costs.